{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:17:04Z","timestamp":1790983024167,"version":"4.1.0"},"reference-count":50,"publisher":"American Diabetes Association","issue":"9","content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2007,9,1]]},"abstract":"<jats:p>OBJECTIVE\u2014Human islet amyloid polypeptide (hIAPP) aggregation plays a major role in the development of islet amyloidosis in type 2 diabetes. It is known that extracellular hIAPP oligomers are toxic to pancreatic \u03b2-cells and associated with apoptosis. We therefore investigated the molecular mechanism by which extracellular hIAPP mediates pancreatic \u03b2-cell apoptosis.<\/jats:p>\n               <jats:p>RESEARCH DESIGN AND METHODS\u2014MIN6 cells and primary cultures of human pancreatic islets were treated with freshly dissolved hIAPP peptide. Morphology of the cultures was evaluated by electron microscopy. Gene expression was analyzed by microarray, RT-PCR, and immunoblot. Calcium levels were measured in fura-2\u2013loaded cells. Apoptosis was quantified by cytometry.<\/jats:p>\n               <jats:p>RESULTS\u2014Increased expression of several heat shock proteins and activation of the spliced form of XBP-1, a transcription factor for overexpression of chaperones during endoplasmic reticulum (ER) stress, were detected together with morphological evidence of ER dysfunction. Intracellular calcium overload was detected in association with this process. Moreover, reduction in the proteasome activity, which was detected over time, contributed to the intracellular accumulation of ubiquitinated proteins, leading to a functional suppression of the ubiquitin-proteasome pathway. In addition, impairment of the proteasome function contributed to apoptosis, while, despite the presence of hIAPP, cell viability improved when a proteasome activator was overexpressed. The key cytotoxic events induced by extracellular hIAPP were also observed in treated human islets.<\/jats:p>\n               <jats:p>CONCLUSIONS\u2014Our data suggest that ER stress responses are intracellular signaling mechanisms induced by extracellular hIAPP aggregation and that impairment of the ubiquitin-proteasome pathway is implicated in ER stress\u2013mediated pancreatic \u03b2-cell apoptosis.<\/jats:p>","DOI":"10.2337\/db07-0178","type":"journal-article","created":{"date-parts":[[2007,8,28]],"date-time":"2007-08-28T17:28:04Z","timestamp":1188322084000},"page":"2284-2294","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":131,"title":["Impairment of the Ubiquitin-Proteasome Pathway Is a Downstream Endoplasmic Reticulum Stress Response Induced by Extracellular Human Islet Amyloid Polypeptide and Contributes to Pancreatic \u03b2-Cell Apoptosis"],"prefix":"10.2337","volume":"56","author":[{"given":"Si\u0301lvia","family":"Casas","sequence":"first","affiliation":[{"name":"Endocrinology and Diabetes Unit, Laboratory of Experimental Diabetes, IDIBAPS (Institut d'Investigacions Biome\u0300diques August Pi i Sunyer), Hospital Clinic and University of Barcelona, Barcelona, Spain"},{"name":"Institute of Diabetes, Sarda\u0300 Farriol Foundation, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramon","family":"Gomis","sequence":"additional","affiliation":[{"name":"Endocrinology and Diabetes Unit, Laboratory of Experimental Diabetes, IDIBAPS (Institut d'Investigacions Biome\u0300diques August Pi i Sunyer), Hospital Clinic and University of Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona M.","family":"Gribble","sequence":"additional","affiliation":[{"name":"Cambridge Institute for Medical Research, University of Cambridge, Department of Clinical Biochemistry, Wellcome Trust\/MRC Building, Addenbrooke's Hospital, Cambridge, U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Altirriba","sequence":"additional","affiliation":[{"name":"Endocrinology and Diabetes Unit, Laboratory of Experimental Diabetes, IDIBAPS (Institut d'Investigacions Biome\u0300diques August Pi i Sunyer), Hospital Clinic and University of Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakari","family":"Knuutila","sequence":"additional","affiliation":[{"name":"Laboratory of Cytomolecular Genetics, Department of Pathology, Haartman Institute, University of Helsinki and HUSLAB, Helsinki, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Novials","sequence":"additional","affiliation":[{"name":"Institute of Diabetes, Sarda\u0300 Farriol Foundation, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","reference":[{"key":"2022031208222389100_R1","doi-asserted-by":"crossref","unstructured":"Westermark P, Grimelius L: The pancreatic islet cells in insular amyloidosis in human diabetic and non-diabetic adults. Acta Pathol Microbiol Scand A\u200881:291\u2013300,1973","DOI":"10.1111\/j.1699-0463.1973.tb03538.x"},{"key":"2022031208222389100_R2","doi-asserted-by":"crossref","unstructured":"Howard CF Jr: Longitudinal studies on the development of diabetes in individual Macaca nigra. Diabetologia\u200829:301\u2013306,1986","DOI":"10.1007\/BF00452067"},{"key":"2022031208222389100_R3","doi-asserted-by":"crossref","unstructured":"Westermark P, Wernstedt C, Wilander E, Hyden DW, O'Brien TD, Johnson KH: Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells. Proc Natl Acad Sci U S A\u200884:3881\u20133885,1987","DOI":"10.1073\/pnas.84.11.3881"},{"key":"2022031208222389100_R4","doi-asserted-by":"crossref","unstructured":"Clark A, Cooper GJ, Lewis CE, Morris JF, Willis AC, Reid KB, Turner RC: Islet amyloid formed from diabetes-associated peptide may be pathogenic in type-2 diabetes. Lancet\u20082:231\u2013234,1987","DOI":"10.1016\/S0140-6736(87)90825-7"},{"key":"2022031208222389100_R5","doi-asserted-by":"crossref","unstructured":"Kahn SE, D'Alessio DA, Schwartz MW, Fujimoto WY, Ensinck JW, Taborsky GJ Jr, Porte D Jr: Evidence of cosecretion of islet amyloid polypeptide and insulin by beta-cells. Diabetes\u200839:634\u2013638,1990","DOI":"10.2337\/diabetes.39.5.634"},{"key":"2022031208222389100_R6","doi-asserted-by":"crossref","unstructured":"Novials A, Sarri Y, Casamitjana R, Rivera F, Gomis R: Regulation of islet amyloid polypeptide in human pancreatic islets. Diabetes\u200842:1514\u20131519,1993","DOI":"10.2337\/diabetes.42.10.1514"},{"key":"2022031208222389100_R7","doi-asserted-by":"crossref","unstructured":"Gasa R, Gomis R, Casamitjana R, Novials A: Signals related to glucose metabolism regulate islet amyloid polypeptide (IAPP) expression in human pancreatic islets. Regul Pept\u200868:99\u2013104,1997","DOI":"10.1016\/S0167-0115(96)02109-X"},{"key":"2022031208222389100_R8","doi-asserted-by":"crossref","unstructured":"Westermark P, Engstro\u0308m U, Johnson KH, Westermark GT, Betsholtz C: Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation. Proc Natl Acad Sci U S A\u200887:5036\u20135040,1990","DOI":"10.1073\/pnas.87.13.5036"},{"key":"2022031208222389100_R9","doi-asserted-by":"crossref","unstructured":"Sakagashira S, Hiddinga HJ, Tateishi K, Sanke T, Hanabusa T, Nanjo K, Eberhardt NL: S20G mutant amylin exhibits increased in vitro amyloidogenicity and increased intracellular cytotoxicity compared to wild type amylin. Am J Pathol\u2008157:2101\u20132109,2000","DOI":"10.1016\/S0002-9440(10)64848-1"},{"key":"2022031208222389100_R10","unstructured":"Novials A, Rojas I, Casamitjana R, Usac EF, Gomis R: A novel mutation in islet amyloid polypeptide (IAPP) gene promoter is associated with type II diabetes mellitus. Diabetologia\u200844:1064\u20131065,2001"},{"key":"2022031208222389100_R11","doi-asserted-by":"crossref","unstructured":"Hull RL, Westermark GT, Westermark P, Kahn SE: Islet amyloid: a critical entity in the pathogenesis of type 2 diabetes. J Clin Endocrinol Metab\u200889:3629\u20133643,2004","DOI":"10.1210\/jc.2004-0405"},{"key":"2022031208222389100_R12","doi-asserted-by":"crossref","unstructured":"Lorenzo A, Razzaboni B, Weir GC, Yankner BA: Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus. Nature\u2008368:756\u2013760,1994","DOI":"10.1038\/368756a0"},{"key":"2022031208222389100_R13","doi-asserted-by":"crossref","unstructured":"Janson J, Soeller WC, Roche PC, Nelson RT, Torchia AJ, Kreutter DK, Butler PC: Spontaneous diabetes mellitus in transgenic mice expressing islet amyloid polypeptide. Proc Natl Acad Sci U S A\u200893:7283\u20137288,1996","DOI":"10.1073\/pnas.93.14.7283"},{"key":"2022031208222389100_R14","doi-asserted-by":"crossref","unstructured":"Butler AE, Jang J, Gurlo T, Carty MD, Soeller WC, Butler PC: Diabetes due to a progressive defect in \u03b2-cell mass in rats transgenic for human islet amyloid polypeptide (HIP rat): a new model for type 2 diabetes. Diabetes\u200853:1509\u20131516,2004","DOI":"10.2337\/diabetes.53.6.1509"},{"key":"2022031208222389100_R15","doi-asserted-by":"crossref","unstructured":"Janson J, Ashley RH, Harrison D, McIntyre S, Butler PC: The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles. Diabetes\u200848:491\u2013498,1999","DOI":"10.2337\/diabetes.48.3.491"},{"key":"2022031208222389100_R16","doi-asserted-by":"crossref","unstructured":"Demuro A, Mina E, Kayed R, Milton SC, Parker I, Glabe CG: Calcium dysrerugulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers. J Biol Chem\u2008280:1794\u201317300,2005","DOI":"10.1074\/jbc.M500997200"},{"key":"2022031208222389100_R17","doi-asserted-by":"crossref","unstructured":"Meier JJ, Kayed R, Lin CY, Gurlo T, Haataja L, Jayasinghe S, Langen R, Glabe CG, Butler PC: Inhibition of human IAPP fibril formation does not prevent \u03b2-cell death: evidence for distinct actions of oligomers and fibrils of human IAPP. Am J Physiol Endocrinol Metab\u2008291:E1317\u2013E1324,2006","DOI":"10.1152\/ajpendo.00082.2006"},{"key":"2022031208222389100_R18","doi-asserted-by":"crossref","unstructured":"Rao RV, Ellerby HN, Bredesen DE: Coupling endoplasmic reticulum stress to cell death program. Cell Death Differ\u200811:372\u2013380,2004","DOI":"10.1038\/sj.cdd.4401378"},{"key":"2022031208222389100_R19","doi-asserted-by":"crossref","unstructured":"McClellan AJ, Tam S, Kaganovich D, Frydman J: Protein quality control: chaperones culling corrupt conformations. Nat Cell Biol\u20087:736\u2013741,2005","DOI":"10.1038\/ncb0805-736"},{"key":"2022031208222389100_R20","doi-asserted-by":"crossref","unstructured":"Glickman MH, Ciechanover A: The ubiquitin-proteasome pathway: destruction of the sake of construction. Physiol Rev\u200882:373\u2013428,2002","DOI":"10.1152\/physrev.00027.2001"},{"key":"2022031208222389100_R21","doi-asserted-by":"crossref","unstructured":"Ciechanover A: Proteolysis: from the lysosome to ubiquitin and the proteasome. Nat Rev Mol Cell Biol\u20086:79\u201387,2005","DOI":"10.1038\/nrm1552"},{"key":"2022031208222389100_R22","doi-asserted-by":"crossref","unstructured":"Araki E, Oyadomari S, Mori M: Impact of endoplasmic reticulum stress pathway on pancreatic beta-cells and diabetes mellitus. Exp Biol Med (Maywood)\u2008228:1213\u20131217,2003","DOI":"10.1177\/153537020322801018"},{"key":"2022031208222389100_R23","doi-asserted-by":"crossref","unstructured":"Mattson MP, Goodman Y: Different amyloidogenic peptides share a similar mechanism of neurotoxicity involving reactive reactive oxygen species and calcium. Brain Res\u2008676:219\u2013224,1995","DOI":"10.1016\/0006-8993(95)00148-J"},{"key":"2022031208222389100_R24","doi-asserted-by":"crossref","unstructured":"Mirzabekov TA, Lin MC, Kagan BL: Pore formation by the cytotoxic islet amyloid peptide amylin. J Biol Chem\u2008271:1988\u20131992,1996","DOI":"10.1074\/jbc.271.4.1988"},{"key":"2022031208222389100_R25","doi-asserted-by":"crossref","unstructured":"Porat Y, Kolusheva S, Jelinek R, Gazit E: The human islet polypeptide forms transient membrane-active prefibrillar assemblies. Biochemistry\u200842:10971\u201310977,2003","DOI":"10.1021\/bi034889i"},{"key":"2022031208222389100_R26","doi-asserted-by":"crossref","unstructured":"Sparr E, Engel MF, Sakharov DV, Sprong M, Jacobs J, de Kruijff B, Hoppener JW, Killian JA: Islet amyloid polypeptide-induced membrane leakage involves uptake of lipids by forming amyloid fibers. FEBS Lett\u2008577:117\u2013120,2004","DOI":"10.1016\/j.febslet.2004.09.075"},{"key":"2022031208222389100_R27","doi-asserted-by":"crossref","unstructured":"Bucciantini M, Calloni C, Chiti F, Formigli L, Nosi D, Dobson CM, Stefani M: Prefibrillar amyloid protein aggregates share common features of cytotoxicity. J Biol Chem\u2008279:31374\u201331382,2004","DOI":"10.1074\/jbc.M400348200"},{"key":"2022031208222389100_R28","doi-asserted-by":"crossref","unstructured":"Cecchi C, Baglioni S, Fiorillo C, Pensalfini A, Liguri G, Nosi D, Rigacci S, Bucciantini M, Stefani M: Insights into the molecular basis of the differing susceptibility of varying cell types to the toxicity of amyloid aggregates. J Cell Sci\u2008118:3459\u20133470,2005","DOI":"10.1242\/jcs.02473"},{"key":"2022031208222389100_R29","doi-asserted-by":"crossref","unstructured":"Nakagawa T, Zhu H, Morishima N, Li E, Xu J, Yankner BA, Yuan J: Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-\u03b2. Nature\u2008403:98\u2013103,2000","DOI":"10.1038\/47513"},{"key":"2022031208222389100_R30","doi-asserted-by":"crossref","unstructured":"Pereira C, Ferreiro E, Cardoso SM, de Oliveira CR: Cell degeneration induced by amyloid-beta peptides: implication for Alzheimer's disease. J Mol Neurosci\u200823:97\u2013104,2004","DOI":"10.1385\/JMN:23:1-2:097"},{"key":"2022031208222389100_R31","doi-asserted-by":"crossref","unstructured":"Teixeira PF, Cerca F, Santos SD, Saraiva MJ: Endoplasmic reticulum stress associated with extracellular aggregates: evidence from transthyretin deposition in familial amyloid polyneuropathy. J Biol Chem\u2008281:21998\u201322003,2006","DOI":"10.1074\/jbc.M602302200"},{"key":"2022031208222389100_R32","doi-asserted-by":"crossref","unstructured":"Ishihara H, Asano T, Tsukuda K, Katagiri H, Inukai K, Anai M, Kikuchi M, Yazaki Y, Miyazaki JI, Oka Y: Pancreatic \u03b2-cell line MIN6 exhibits characteristics of glucose metabolism and glucose-stimulated insulin secretion similar to those of normal islets. Diabetologia\u200836:1139\u20131145,1993","DOI":"10.1007\/BF00401058"},{"key":"2022031208222389100_R33","doi-asserted-by":"crossref","unstructured":"Coronado-Pons I, Novials A, Casas S, Clark A, Gomis R: Identification of iduronate-2-sulfatase in mouse pancreatic islets. Am J Physiol Endocrinol Metab\u2008287:E983\u2013E990,2004","DOI":"10.1152\/ajpendo.00528.2003"},{"key":"2022031208222389100_R34","doi-asserted-by":"crossref","unstructured":"Dantuma NP, Lindsten K, Glas R, Jellne M, Masucci MG: Short-lived green fluorescent proteins for quantifying ubiquitin\/proteasome-dependent proteolysis in living cells. Nat Biotechnol\u200818:538\u2013543,2000","DOI":"10.1038\/75406"},{"key":"2022031208222389100_R35","doi-asserted-by":"crossref","unstructured":"Csermely P, Schnaider T, Soti C, Prohaszka Z, Nardai G: The 90-KDa molecular chaperone family: structure, function and clinical applications: a comprehensive review. Pharmacol Ther\u200879:129\u2013168,1998","DOI":"10.1016\/S0163-7258(98)00013-8"},{"key":"2022031208222389100_R36","doi-asserted-by":"crossref","unstructured":"Nozaki J, Kubota H, Yoshida H, Naitoh M, Goji J, Yoshinaga T, Mori K, Koizumi A, Nagata K: The endoplasmic reticulum stress response is stimulated through the continious activation of transcription factors ATF6 and XBP1 in Ins2+\/Akita pancreatic \u03b2-cells. Genes Cells\u20089:261\u2013270,2004","DOI":"10.1111\/j.1356-9597.2004.00721.x"},{"key":"2022031208222389100_R37","doi-asserted-by":"crossref","unstructured":"Bai JZ, Saafi EL, Zhang S, Cooper GJS: Role of Ca2+ in apoptosis evoked by human amylin in pancreatic islet \u03b2-cells. Biochem J\u2008343:53\u201361,1999","DOI":"10.1042\/bj3430053"},{"key":"2022031208222389100_R38","doi-asserted-by":"crossref","unstructured":"Keller JN, Hanni KB, Markesbery WR: Impaired proteasome function in Alzheimer's disease. J Neurochem\u200875:436\u2013439,2000","DOI":"10.1046\/j.1471-4159.2000.0750436.x"},{"key":"2022031208222389100_R39","doi-asserted-by":"crossref","unstructured":"Bence NF, Sampat RM, Kopito RR: Impairment of the ubiquitin-proteasome system by protein aggregation. Science\u2008292:1552\u20131555,2001","DOI":"10.1126\/science.292.5521.1552"},{"key":"2022031208222389100_R40","doi-asserted-by":"crossref","unstructured":"Keller JN, Hanni KB, Markesbery WR: Possible involvement of proteasome inhibition in aging: implication for oxidative stress. Mech Ageing Dev\u2008113:61\u201370,2000","DOI":"10.1016\/S0047-6374(99)00101-3"},{"key":"2022031208222389100_R41","doi-asserted-by":"crossref","unstructured":"Lam YA, Pickart CM, Alban A, Landon M, Jamieson C, Ramage R, Mayer RJ, Layfield R: Inhibition of ubiquitin-proteasome system in Alzheimer's disease. Proc Natl Acad Sci U S A\u200897:9902\u20139906,2000","DOI":"10.1073\/pnas.170173897"},{"key":"2022031208222389100_R42","doi-asserted-by":"crossref","unstructured":"McNaught KS, Jenner P: Proteasomal function is impaired in substantia nigra in Parkinson's disease. Neurosci Lett\u2008297:191\u2013194,2001","DOI":"10.1016\/S0304-3940(00)01701-8"},{"key":"2022031208222389100_R43","doi-asserted-by":"crossref","unstructured":"Waelter S, Boeddrich A Lurz R, Scherzinger E, Lueder G, Lehrach H, Wanker EE: Accumulation of huntingting fragments in aggresome-like inclusion bodies as a result of insufficient protein degradation. Mol Biol Cell\u200812:1393\u20131407,2001","DOI":"10.1091\/mbc.12.5.1393"},{"key":"2022031208222389100_R44","doi-asserted-by":"crossref","unstructured":"Ma J, Wollmann R, Lindquist S: Neurotoxicity and neurodegeneration when PrP accumulates in the cytosol. Science\u2008298:1781\u20131785,2002","DOI":"10.1126\/science.1073725"},{"key":"2022031208222389100_R45","doi-asserted-by":"crossref","unstructured":"Song S, Kim SY, Hong YM, Jo DG, Lee JY, Shim SM, Chung CW, Seo SJ, Yoo YJ, Koh JY, Lee MC, Yates AJ, Ichijo H, Jung YK: Essential role of E2\u201325K\/Hip-2 in mediating amyloid-\u03b2 neurotoxicity. Mol Cell\u200812:553\u2013563,2003","DOI":"10.1016\/j.molcel.2003.08.005"},{"key":"2022031208222389100_R46","doi-asserted-by":"crossref","unstructured":"St\u00f8rling J, Allaman-Pillet N, Karlsen AE, Billestrup N, Bonny C, Mandrup-Poulsen T: Antitumorigenic effect of proteasome inhibitors on insulinoma cells. Endocrinology\u2008146:1718\u20131726,2005","DOI":"10.1210\/en.2004-0963"},{"key":"2022031208222389100_R47","doi-asserted-by":"crossref","unstructured":"Lindsten K, Menendez-Benito V, Masucci M, Dantuma NP: A transgenic mouse model of the ubiquitin\/proteasome system. Nat Biotechnol\u200821:897\u2013902,2003","DOI":"10.1038\/nbt851"},{"key":"2022031208222389100_R48","doi-asserted-by":"crossref","unstructured":"Rumora L, Hadzija M, Barisic K, Maysinger D, Grubiic TZ: Amylin-induced cytotoxicity is associated with activation of caspase-3 and MAP kinases. Biol Chem\u2008383:1751\u20131758,2002","DOI":"10.1515\/BC.2002.196"},{"key":"2022031208222389100_R49","doi-asserted-by":"crossref","unstructured":"Tanaka Y, Engelender S, Igarashi S, Rao RK, Wanner T, Tanzi RE, Sawa A, Dawson V, Dawson TM, Ross CA: Inducible expression of mutant alpha-synuclein decreases proteasome activity and increases sensitivity to mitochondria-dependent apoptosis. Hum Mol Genet\u200810:919\u2013926,2001","DOI":"10.1093\/hmg\/10.9.919"},{"key":"2022031208222389100_R50","doi-asserted-by":"crossref","unstructured":"Valente EM, Abou-Sleiman PM, Caputo V, Muqit MM, Harvey K, Gispert S, Ali Z, Del Turco D, Bentivoglio AR, Healy DG, Albanese A, Nussbaum R, Gonzalez-Maldonado R, Deller T, Salvi S, Cortelli P, Gilks WP, Latchman DS, Harvey RJ, Dallapiccola B, Auburger G, Wood NW: Hereditary early-onset Parkinson's disease caused by mutations in PINK1 gene. Science\u2008304:1158\u20131160,2004","DOI":"10.1126\/science.1096284"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.org\/diabetes\/diabetes\/article-pdf\/56\/9\/2284\/388799\/zdb00907002284.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/56\/9\/2284\/388799\/zdb00907002284.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T16:11:16Z","timestamp":1667405476000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/56\/9\/2284\/12682\/Impairment-of-the-Ubiquitin-Proteasome-Pathway-Is"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9,1]]},"references-count":50,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2007,9,1]]}},"URL":"https:\/\/doi.org\/10.2337\/db07-0178","relation":{},"ISSN":["0012-1797","1939-327X"],"issn-type":[{"value":"0012-1797","type":"print"},{"value":"1939-327X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,9,1]]}}}